PubRank

J Zapf

Author PubWeight™ 167.28‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Actions of insulin-like growth factors. Annu Rev Physiol 1985 3.80
2 Insulin-like growth factor I stimulates growth in hypophysectomized rats. Nature 1982 2.79
3 Radioimmunological determination of insulinlike growth factors I and II in normal subjects and in patients with growth disorders and extrapancreatic tumor hypoglycemia. J Clin Invest 1981 2.52
4 Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults. N Engl J Med 1987 2.00
5 Insulin-like growth factors I and II: some biological actions and receptor binding characteristics of two purified constituents of nonsuppressible insulin-like activity of human serum. Eur J Biochem 1978 1.88
6 Insulin-like growth factors I and II in healthy man. Estimations of half-lives and production rates. Acta Endocrinol (Copenh) 1989 1.83
7 Synthesis and secretion of insulin-like growth factor and its binding protein by the perfused rat liver: dependence on growth hormone status. Endocrinology 1983 1.72
8 The insulin-like growth factors (IGF) of human serum: chemical and biological characterization and aspects of their possible physiological role. Curr Top Cell Regul 1981 1.63
9 Insulin-like growth factors in pygmies. The role of puberty in determining final stature. N Engl J Med 1987 1.55
10 Recombinant human insulin-like growth factor I stimulates growth and has distinct effects on organ size in hypophysectomized rats. Proc Natl Acad Sci U S A 1988 1.55
11 Binding of nonsuppressible insulinlike activity to human serum. Evidence for a carrier protein. Arch Biochem Biophys 1975 1.52
12 Interactions of insulin-like growth factors I and II and multiplication-stimulating activity with receptors and serum carrier proteins. Endocrinology 1980 1.48
13 Insulin-like growth factor II in human adrenal pheochromocytomas and Wilms tumors: expression at the mRNA and protein level. Proc Natl Acad Sci U S A 1987 1.47
14 Nonsuppressible insulin-like activity and thyroid hormones: major pituitary-dependent sulfation factors for chick embryo cartilage. Proc Natl Acad Sci U S A 1976 1.45
15 Nonsuppressible insulin-like activity (NSILA) from human serum: recent accomplishments and their physiologic implications. Metabolism 1978 1.40
16 Insulin-like growth factors. Studies in diabetics with and without retinopathy. N Engl J Med 1983 1.38
17 Growth restoration of insulin-deficient diabetic rats by recombinant human insulin-like growth factor I. Nature 1986 1.37
18 Biological and immunological properties of insulin-like growth factors (IGF) I and II. Clin Endocrinol Metab 1984 1.35
19 Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats. J Clin Invest 1986 1.35
20 Effects of recombinant insulin-like growth factor I on insulin secretion and renal function in normal human subjects. Proc Natl Acad Sci U S A 1989 1.33
21 Effects and binding of insulin-like growth factor I in the isolated soleus muscle of lean and obese mice: comparison with insulin. Endocrinology 1979 1.32
22 Inhibition of the action of nonsuppressible insulin-like activity on isolated rat fat cells by binding to its carrier protein. J Clin Invest 1979 1.28
23 Direct effects of leptin on brown and white adipose tissue. J Clin Invest 1997 1.22
24 Insulin-like growth factors and insulin: comparative aspects. Diabetologia 1985 1.20
25 Effect of trypsin treatment of rat adipocytes on biological effects and binding of insulin and insulin-like growth factors: further evidence for the action of insulin-like growth factors through the insulin receptor. Eur J Biochem 1981 1.18
26 Comparison of in vivo effects of insulin-like growth factors I and II and of growth hormone in hypophysectomized rats. Acta Endocrinol (Copenh) 1985 1.16
27 Dwarfism in the pygmy. An isolated deficiency of insulin-like growth factor I. N Engl J Med 1981 1.13
28 Posttranslational regulation of insulin-like growth factor binding protein-4 in normal and transformed human fibroblasts. Insulin-like growth factor dependence and biological studies. J Clin Invest 1993 1.13
29 Crystal structure of a phosphatase-resistant mutant of sporulation response regulator Spo0F from Bacillus subtilis. Structure 1996 1.13
30 Non-suppressible insulin-like activity and sulphaton activity in serum extracts of normal subjects, acromegalics and pituitary dwarfs. Acta Endocrinol (Copenh) 1976 1.12
31 Activity in fetal bovine serum that stimulates erythroid colony formation in fetal mouse livers is insulinlike growth factor I. J Clin Invest 1985 1.12
32 Insulin-like growth factors I and II, prolactin, and insulin in 19 growth hormone-deficient children with excessive, normal, or decreased longitudinal growth after operation for craniopharyngioma. N Engl J Med 1983 1.10
33 Serum levels of insulin-like growth factor (IGF) and its carrier protein in various metabolic disorders. Acta Endocrinol (Copenh) 1980 1.09
34 Insulin and non-suppressible insulin-like activity (NSILA-s): evidence for separate plasma membrane receptor sites. Biochem Biophys Res Commun 1974 1.09
35 Insulin-like growth factors in the fed and fasted states. J Clin Endocrinol Metab 1982 1.08
36 Differential effects of insulin-like growth factor I and growth hormone on developmental stages of rat growth plate chondrocytes in vivo. J Clin Invest 1994 1.08
37 Role of muscle insulin-like growth factors in nerve sprouting: suppression of terminal sprouting in paralyzed muscle by IGF-binding protein 4. J Cell Biol 1994 1.07
38 Insulin-like growth factors (IGF) 1 and 2 in human foetal plasma and relationship to gestational age and foetal size during midpregnancy. Acta Endocrinol (Copenh) 1985 1.07
39 Is extrapancreatic tumor hypoglycemia associated with elevated levels of insulin-like growth factor II? J Clin Endocrinol Metab 1982 1.03
40 NSILA-carrier protein abolishes the action of nonsuppressible insulin-like activity (NSILA-S) on perfused rat heart. Diabetologia 1978 1.03
41 Repopulation of the atrophied thymus in diabetic rats by insulin-like growth factor I. Proc Natl Acad Sci U S A 1990 1.03
42 A response regulatory protein with the site of phosphorylation blocked by an arginine interaction: crystal structure of Spo0F from Bacillus subtilis. Biochemistry 1997 1.02
43 Stabilizing insulin-like growth factor-I in poly(D,L-lactide-co-glycolide) microspheres. J Control Release 2001 1.02
44 Proteolysis of insulin-like growth factors (IGF) and IGF binding proteins by cathepsin D. Endocrinology 1997 1.01
45 Human fetal and adult chondrocytes. Effect of insulinlike growth factors I and II, insulin, and growth hormone on clonal growth. J Clin Invest 1986 0.98
46 Molecular cloning of a new human insulin-like growth factor binding protein. Biochem Biophys Res Commun 1991 0.98
47 Hepatic and pulmonary metastases from a meningeal hemangiopericytoma and severe hypoglycemia due to abnormal secretion of insulin-like growth factor: a case report. Cancer 1999 0.97
48 Specific binding of nonsupressible insulinlike activity to chicken embryo fibroblasts and to a solubilized fibroblast receptor. Arch Biochem Biophys 1975 0.97
49 Insulin-like growth factor I stimulates myofibril development and decreases smooth muscle alpha-actin of adult cardiomyocytes. Proc Natl Acad Sci U S A 1994 0.97
50 Insulin-like growth factor I stimulates lipid oxidation, reduces protein oxidation, and enhances insulin sensitivity in humans. J Clin Invest 1993 0.97
51 Molecular mechanism of action at estrogen receptor alpha of a new clinically relevant antiestrogen (GW7604) related to tamoxifen. Endocrinology 2001 0.97
52 Identification and molecular cloning of two new 30-kDa insulin-like growth factor binding proteins isolated from adult human serum. J Biol Chem 1991 0.96
53 Characterization of recombinant human insulin-like growth factor binding proteins 4, 5, and 6 produced in yeast. J Biol Chem 1992 0.95
54 Carboxy-truncated insulin-like growth factor binding protein-5 stimulates mitogenesis in osteoblast-like cells. Biochem Biophys Res Commun 1993 0.94
55 Regulation of insulin-like growth factor-I (IGF-I) and IGF-binding proteins by growth hormone in rat white adipose tissue. Endocrinology 1993 0.94
56 Tumour hypoglycaemia: raised tumour IGFII mRNA associated with reduced plasma somatomedins. Br J Cancer 1989 0.93
57 Insulin-like growth factor I stimulates erythropoiesis in hypophysectomized rats. Proc Natl Acad Sci U S A 1988 0.93
58 Insulin-like growth factor-binding protein 5 complexes with the acid-labile subunit. Role of the carboxyl-terminal domain. J Biol Chem 1998 0.93
59 Tumor necrosis factor alpha is involved in mouse growth and lymphoid tissue development. J Exp Med 1992 0.93
60 Biological properties of NSILA-S. Adv Metab Disord 1975 0.92
61 Increased levels of circulating free insulin-like growth factors in patients with non-islet cell tumour hypoglycaemia. Diabetologia 1998 0.92
62 Insulin-like growth factor I: physiology, metabolic effects and clinical uses. Diabetes Metab Rev 1996 0.92
63 Effects of insulin and NSILA on adipocytes of normal and diabetic rats: receptor binding, glucose transport and glucose metabolism. Diabetologia 1977 0.92
64 Insulin-like growth factor I increase glomerular filtration rate and renal plasma flow in man. Acta Endocrinol (Copenh) 1989 0.92
65 IGF-I in human breast cancer: low differentiation stage is associated with decreased IGF-I content. Eur J Endocrinol 2002 0.91
66 Growth-hormone dependence of non-suppressible insulin-like activity (NSILA) and of NSILA-carrier protein in rats. Acta Endocrinol (Copenh) 1978 0.91
67 Demonstration of a specific serum carrier protein of nonsuppressible insulin-like activity in vivo. J Clin Endocrinol Metab 1977 0.91
68 Determination of nonsuppressible insulin-like activity in human serum by a sensitive protein-binding assay. Clin Chem 1977 0.91
69 Increased sensitivity of rat adipose tissue to the lipolytic action of epinephrine during fasting and its reversal during re-feeding. FEBS Lett 1977 0.90
70 Progesterone-controlled growth hormone overproduction and naturally occurring canine diabetes and acromegaly. Acta Endocrinol (Copenh) 1983 0.90
71 Leptin is suppressed during infusion of recombinant human insulin-like growth factor I (rhIGF I) in normal rats. Diabetologia 1999 0.90
72 Expression and regulation of insulin-like growth factor-I (IGF-I) and IGF-binding protein messenger ribonucleic acid levels in tissues of hypophysectomized rats infused with IGF-I and growth hormone. Endocrinology 1994 0.90
73 Improvement of growth and food utilization by human recombinant growth hormone in uremia. Kidney Int 1988 0.89
74 Acute cardiovascular effects of insulin-like growth factor I in patients with chronic heart failure. J Clin Endocrinol Metab 1998 0.89
75 Insulin regulates the expression of the insulin-like growth factor binding protein 2 mRNA in rat hepatocytes. Mol Endocrinol 1990 0.89
76 Pathophysiological and clinical aspects of the insulin-like growth factors. Horm Res 1986 0.89
77 Insulin-like growth factors/somatomedins: structure, secretion, biological actions and physiological role. Horm Res 1986 0.89
78 Growth promoting effects of growth hormone and IGF-I are additive in experimental uremia. Kidney Int 1996 0.88
79 Cleavage analysis of insulin-like growth factor (IGF)-dependent IGF-binding protein-4 proteolysis and expression of protease-resistant IGF-binding protein-4 mutants. J Biol Chem 1995 0.88
80 Receptor binding and effects of insulin and NSILA-S on glucose transport and metabolism in adipocytes from hypophysectomized rats. Diabetologia 1979 0.88
81 Comparison of the effects of growth hormone and insulin-like growth factor I on substrate oxidation and on insulin sensitivity in growth hormone-deficient humans. J Clin Invest 1994 0.87
82 Evidence for the existence in human serum of large molecular weight nonsuppressible insulin-like activity (NSILA) different from the small molecular weight forms. FEBS Lett 1978 0.87
83 Primary structure of rat insulin-like growth factor-I and its biological activities. J Biol Chem 1989 0.87
84 Intact but not truncated insulin-like growth factor binding protein-3 (IGFBP-3) blocks IGF I-induced stimulation of osteoblasts: control of IGF signalling to bone cells by IGFBP-3-specific proteolysis? Biochem Biophys Res Commun 1991 0.87
85 Effect of growth hormone and insulin-like growth factor I (IGF-I) on the expression of IGF-I messenger ribonucleic acid and peptide in rat tibial growth plate and articular chondrocytes in vivo. Endocrinology 2000 0.86
86 Regulation of phosphate (Pi) transport and NaPi-III transporter (Pit-1) mRNA in rat osteoblasts. J Endocrinol 2004 0.86
87 Effects of hormones on cyclic AMP release in perfused rat livers. FEBS Lett 1973 0.86
88 Effects of insulin on glucose metabolism and glucose transport in fat cells of hormone-treated hypophysectomized rats: evidence that growth hormone restricts glucose transport. Endocrinology 1979 0.86
89 Pregnancy-associated plasma protein-A (PAPP-A) in ovine, bovine, porcine, and equine ovarian follicles: involvement in IGF binding protein-4 proteolytic degradation and mRNA expression during follicular development. Endocrinology 2001 0.86
90 Measurements of growth hormone and insulin-like growth factor 1 in cats with diabetes mellitus. Vet Rec 2006 0.85
91 Insulin-like growth factor-I stimulates myofibrillar genes and modulates atrial natriuretic factor mRNA in rat heart. Eur J Endocrinol 1997 0.85
92 Reduced ob mRNA in hypophysectomised rats is not restored by growth hormone (GH), but further suppressed by exogenously administered insulin-like growth factor (IGF) I. Biochem Biophys Res Commun 1996 0.85
93 Effect of insulin on glucose transport and metabolism in adipose tissue and skeletal muscle of hypophysectomized rats. FEBS Lett 1981 0.84
94 Mechanisms of insulin-like growth factor regulation of programmed cell death of developing avian motoneurons. J Neurobiol 1998 0.84
95 Effects of insulin-like growth factors on chick embryo hepatocytes. Acta Endocrinol (Copenh) 1985 0.83
96 Hypoglycemia in hepatocellular carcinoma: failure of short-term growth hormone administration to reduce enhanced glucose requirements. Metabolism 1991 0.83
97 Insulin-like growth factor I in the dog: a study in different dog breeds and in dogs with growth hormone elevation. Acta Endocrinol (Copenh) 1984 0.83
98 Two insulin-like growth factor (IGF)-binding proteins are responsible for the selective affinity for IGF-II of cerebrospinal fluid binding proteins. J Clin Endocrinol Metab 1991 0.83
99 Transport and metabolism of fructose in fat cells of normal and hypophysectomized rats. Am J Physiol 1979 0.82
100 Inhibition of insulin degradation by insulin-like growth factors I and II in human hepatoma (HepG2) cells. Acta Endocrinol (Copenh) 1989 0.82
101 Hepatoma with severe non-islet cell tumor hypoglycemia. Am J Gastroenterol 1998 0.82
102 Insulin-like growth factor (IGF) I down-regulates type 1 IGF receptor (IGF 1R) and reduces the IGF I response in A549 non-small-cell lung cancer and Saos-2/B-10 osteoblastic osteosarcoma cells. Exp Cell Res 2001 0.82
103 Phex cDNA cloning from rat bone and studies on phex mRNA expression: tissue-specificity, age-dependency, and regulation by insulin-like growth factor (IGF) I in vivo. Mol Cell Endocrinol 2000 0.82
104 Effects of IGF-I on cardiac growth and expression of mRNAs coding for cardiac proteins after induction of heart hypertrophy in the rat. Eur J Endocrinol 1998 0.82
105 Insulin-like growth factor in pregnancy: studies in a growth hormone-deficient dwarf. J Clin Endocrinol Metab 1982 0.82
106 Release of insulin-like growth factor carrier proteins by osteoblasts: stimulation by estradiol and growth hormone. Biochem Biophys Res Commun 1989 0.81
107 Skeletal growth and bone density as sensitive parameters in experimental arthritis: effect of cyclosporin A. Bone 1995 0.81
108 Is increased basal lipolysis in adipose tissue of fasted-refed rats related to cyclic-AMP-dependent mechanisms? Eur J Biochem 1981 0.81
109 Replacement of growth hormone (GH) in normally growing GH-deficient patients operated for craniopharyngioma. J Clin Endocrinol Metab 1995 0.81
110 Increased sensitivity to lipolytic hormones of adenylate cyclase in fat cells of diabetic rats. Eur J Biochem 1980 0.81
111 Effects of insulin--like growth factor-I treatment on the endocrine pancreas of hypophysectomized rats: comparison with growth hormone replacement. Eur J Endocrinol 2004 0.81
112 Effects of IGF-I and -II, IGF binding protein-3 (IGFBP-3), and transforming growth factor-beta (TGF-beta) on growth and apoptosis of human osteosarcoma Saos-2/B-10 cells: lack of IGF-independent IGFBP-3 effects. Eur J Endocrinol 2001 0.81
113 Expression, effects, and fate of IGFBP-5 are different in normal and malignant osteoblastic cells. Prog Growth Factor Res 1995 0.81
114 Transferrin binds insulin-like growth factors and affects binding properties of insulin-like growth factor binding protein-3. FEBS Lett 2001 0.80
115 Effects and fate of human IGF-binding protein-5 in rat osteoblast cultures. Am J Physiol 1996 0.80
116 Insulin-like growth factors in the Göttinger miniature-pig. Acta Endocrinol (Copenh) 1988 0.80
117 In vivo effects of the insulin-like growth factors (IGFs) in the hypophysectomized rat: comparison with human growth hormone and the possible role of the specific IGF carrier proteins. Ciba Found Symp 1985 0.80
118 Regulation of rat adipocyte glucose transport by growth hormone: no mediation by insulin-like growth factors. Endocrinology 1983 0.80
119 Production of carrier proteins for insulin-like growth factors (IGFs) by rat osteoblastic cells. Regulation by IGF I and cortisol. FEBS Lett 1989 0.80
120 The role of insulin-like growth factor I in growth of diabetic rats. Acta Endocrinol (Copenh) 1989 0.79
121 Proteolysis of IGFBPs by cathepsin D in vitro and in cathepsin D-deficient mice. Prog Growth Factor Res 1995 0.79
122 Mitogenic and antiapoptotic effects of insulin-like growth factor binding protein-6 in the human osteoblastic osteosarcoma cell line Saos-2/B-10. Biochem Biophys Res Commun 1999 0.79
123 Triiodothyronine increases glucose transporter isotype 4 mRNA expression, glucose transport, and glycogen synthesis in adult rat cardiomyocytes in long-term culture. Biochem Biophys Res Commun 1996 0.79
124 Binding of nonsuppressible insulin-like activity (NSILA) to isolated fat cells: evidence for two separate membrane acceptor sites. FEBS Lett 1976 0.79
125 Differential regulation of insulin-like growth factor binding protein (IGFBP)-2 mRNA in liver and bone cells by insulin and retinoic acid in vitro. FEBS Lett 1992 0.79
126 Therapeutic potential of insulinlike growth factor i. Trends Endocrinol Metab 2008 0.79
127 Effects of hormones on cyclic AMP release from rat adipose tissue in vitro. FEBS Lett 1974 0.79
128 Effect of insulin on glucose transporter distribution in white fat cells from hypophysectomized rats. FEBS Lett 1989 0.79
129 Increased sensitivity of diabetic rat adipose tissue towards the lipolytic action of epinephrine. Diabetologia 1975 0.79
130 Insulin-like growth factor binding protein-4 proteolytic degradation in ovine preovulatory follicles: studies of underlying mechanisms. Endocrinology 1999 0.79
131 Effect of glycemic control on serum insulin-like growth factors in diabetes mellitus. Diabetes 1984 0.79
132 Therapy of malignant brain tumors: comparison of the in vitro activities of vidarabin-monophosphate, BCNU and 5-fluorouracil. Acta Neurol Scand 1987 0.79
133 Vidarabin-monophosphate, BCNU, VM26--an in vitro comparative study of active agents in the treatment of malignant human brain tumours. Br J Cancer 1987 0.78
134 Crystallization and preliminary X-ray analysis of a Y13S mutant of Spo0F from Bacillus subtilis. Acta Crystallogr D Biol Crystallogr 1996 0.78
135 Insulin-like growth factor binding protein (IGFBP-3), an inhibitor of serum growth factors other than IGF-I and -II. J Cell Physiol 1992 0.78
136 Valid measurements of total IGF concentrations in biological fluids. Recommendations from the 3rd International Symposium on Insulin-like Growth Factors. J Endocrinol 1994 0.78
137 Decrease of non-suppressible insulin-like activity after pancreatectomy and normalization by insulin therapy. Acta Endocrinol (Copenh) 1977 0.78
138 Proteolysis of insulin-like growth factor binding proteins by a novel 50-kilodalton metalloproteinase in human pregnancy serum. Endocrinology 1998 0.78
139 Heterogeneity of insulin and insulin-like growth factor I binding in a human Burkitt type ALL cell line during the cell cycle and in three Burkitt type ALL sublines. Leukemia 1988 0.78
140 Hypoglycemia associated with non-islet-cell tumor and insulin-like growth factors. N Engl J Med 1982 0.78
141 Effects of insulin-like growth factor I in man. Acta Paediatr Scand Suppl 1990 0.78
142 Prostaglandin E2 stimulates synthesis of insulin-like growth factor binding protein-3 in rat bone cells in vitro. J Bone Miner Res 1992 0.77
143 Metabolic effects of insulin-like growth factor-I: a focus on insulin sensitivity. Metabolism 1995 0.77
144 Insulin-like growth factors decrease oxygen-regulated erythropoietin production by human hepatoma cells (Hep G2). Am J Physiol 1992 0.77
145 1 alpha,25-dihydroxyvitamin D3 increases IGF binding protein-5 expression in cultured osteoblasts. FEBS Lett 1996 0.77
146 Insulin-like growth factor I and cardiac performance in heart failure. Growth Horm IGF Res 1998 0.77
147 Evaluation of IGF-1 levels in cats with transient and permanent diabetes mellitus. Res Vet Sci 2007 0.77
148 In vivo control of insulin-sensitive phosphodiesterase in rat adipocytes by growth hormone and its parallelism to glucose transport. Endocrinology 1981 0.77
149 Glucose transport in adipocytes and its control by growth hormone in vivo. Am J Physiol 1982 0.77
150 Calcium and insulin-like growth factor I stimulation of sodium-dependent phosphate transport and proliferation of cultured rat osteoblasts. Biochem Biophys Res Commun 1998 0.77
151 High molecular weight forms of IGF-II ('big-IGF-II') released by Wilms' tumor cells. Eur J Endocrinol 1997 0.77
152 Increased sensitivity to epinephrine of the cyclic AMP--protein kinase system in adipose tissue of diabetic rats. FEBS Lett 1978 0.77
153 Human nasal septal cartilage: analysis of intracellular enzyme activities, glycogen content, cell density and clonal proliferation of septal chondrocytes of healthy adults and acromegalic patients. Connect Tissue Res 1989 0.77
154 Insulin-like growth factors (IGFs) in pygmies and subjects with the pygmy trait: characterization of the metabolic actions of IGF I and IGF II in man. J Clin Endocrinol Metab 1982 0.77
155 Proteolytic activity is involved in changes in intrafollicular insulin-like growth factor-binding protein levels during growth and atresia of ovine ovarian follicles. Endocrinology 1996 0.77
156 Insulin-like growth factor I: an attractive option for chronic heart failure? Drugs Aging 1999 0.77
157 A central domain binding site in insulin-like growth factor binding protein-5 for the acid-labile subunit. Endocrinology 2000 0.77
158 Growth hormone and parathyroid hormone stimulate IGFBP-3 in rat osteoblasts. Am J Physiol 1994 0.77
159 Production of IGFBP-3 by connective tissue and endothelial cells. Growth Regul 1993 0.76
160 Prevention with glucocorticoids of extrapancreatic tumour-hypoglycaemia as a result of increased 'big' insulin-like growth factor II. J Intern Med 1994 0.76
161 Human leukemic cells: receptor binding and biological effects of insulin and insulin-like growth factors. Leuk Res 1986 0.76
162 Immunohistochemical localization of insulin-like growth factor I and II in the endocrine pancreas of birds, reptiles, and amphibia. Gen Comp Endocrinol 1995 0.76
163 Serum thymidine activity and insulin-like growth factors in the neonatal period. Acta Endocrinol (Copenh) 1985 0.76
164 Growth hormone, but not insulin-like growth factor I, induces a serum protease activity for insulin-like growth factor binding protein-3 in hypophysectomized rats in vivo. FEBS Lett 1993 0.76
165 Insulin-like growth factor-I lowers fasting and postprandial triglyceride levels without affecting chylomicron clearance in healthy men. J Intern Med 1999 0.76
166 Experimental arthritis: effect on growth parameters and total skeletal calcium. Growth Horm IGF Res 2009 0.76
167 Pre-operative treatment of 5 acromegalics with a somatostatin analogue: endocrine and clinical observations. Acta Endocrinol (Copenh) 1987 0.76
168 Triiodothyronine (T3) stimulates insulin-like growth factor (IGF)-1 and IGF binding protein (IGFBP)-2 production by rat osteoblasts in vitro. Acta Endocrinol (Copenh) 1992 0.76
169 Insulin-like growth factors (IGF) I and II and IGF binding proteins (IGFBPs) in human colostrum/transitory milk during the first week postpartum: comparison with neonatal and maternal serum. Biochem Biophys Res Commun 1993 0.76
170 [On acquired lactose intolerance]. Klin Wochenschr 1965 0.76
171 Case 1: hypoglycemic syncope due to a peripheral neuroectodermal tumor. J Clin Oncol 2000 0.76
172 Proteolysis of insulin-like growth factor binding protein-5 by pregnancy serum and amniotic fluid. Endocrinology 1994 0.75
173 Erythropoiesis, serum erythropoietin, and serum IGF-I in rats during accelerated growth. Acta Endocrinol (Copenh) 1990 0.75
174 Triiodothyronine induces over-expression of alpha-smooth muscle actin, restricts myofibrillar expansion and is permissive for the action of basic fibroblast growth factor and insulin-like growth factor I in adult rat cardiomyocytes. J Clin Invest 1996 0.75
175 Recombinant human insulin-like growth factor I: effects in normal subjects and implications for use in patients. Adv Exp Med Biol 1991 0.75
176 [Acromegaly]. Schweiz Rundsch Med Prax 1984 0.75
177 Non-suppressible insulin-like activity during acute metabolic and endocrine changes in dogs. Acta Endocrinol (Copenh) 1977 0.75
178 Insulin-like growth factor 1 and 2 serum concentrations in dialysis patients with secondary hyperparathyroidism and adynamic bone disease. Clin Nephrol 1999 0.75
179 Tumour-induced hypoglycaemia due to 'big' IGF-II. J Intern Med 1994 0.75
180 Nonsuppressible insulin-like activity: biological activity and receptor binding. Isr J Med Sci 1975 0.75
181 Aspartyl phosphates in the regulatory control of bacterial response. Amino Acids 1994 0.75
182 [Quantitative determination of galactose with galactose oxidase from Dactylium dendroides. II. Measurement of the galactose concentration in serum and urine]. Hoppe Seylers Z Physiol Chem 1964 0.75
183 Expression of a high molecular weight form of insulin-like growth factor II in a Beckwith-Wiedemann syndrome associated adrenocortical adenoma. Cancer Lett 1995 0.75
184 [Acromegaly and insulin-like growth factors]. Schweiz Med Wochenschr 1986 0.75
185 Insulin-like growth factor (IGF)-binding protein-4 proteolytic degradation in bovine, equine, and porcine preovulatory follicles: regulation by IGFs and heparin-binding domain-containing peptides. Biol Reprod 2000 0.75
186 The effect of different extraction procedures on two different molecular weight species of serum NSILA and on the carrier protein of small molecular weight NSILA (NSILA-S). Acta Endocrinol (Copenh) 1979 0.75
187 The influence of hypophysectomy on NSILA concentrations in the dog: evidence for partially pituitary-independent regulation. Acta Endocrinol (Copenh) 1977 0.75
188 [Non-suppressible insulin-like serum activity (NSILA). Physiological importance and survey of the current state of research]. Fortschr Med 1980 0.75
189 Insulin-like growth factor I and II in 14 animal species and man as determined by three radioligand assays and two bioassays. Acta Endocrinol (Copenh) 1987 0.75
190 NSILA-S, physiologic and pharmacologic significance as an insulinlike hormone and as a growth-promoting hormone. Adv Metab Disord 1975 0.75
191 IGFs/somatomedins: significance for growth. Prog Clin Biol Res 1985 0.75
192 Purification procedures for NSILA-S. Adv Metab Disord 1975 0.75
193 Biological effects of the insulin-like growth factors in vitro: relevance to their actions in vivo. Bull Schweiz Akad Med Wiss 1983 0.75
194 Comparative study of the metabolism of U- 14 C-fructose, U- 14 C-sorbitol and U- 14 C-xylitol in the normal and in the streptozotocin-diabetic rat. Eur J Clin Invest 1971 0.75
195 Comparison of pancreatic human and biosynthetic human insulin with respect to their action on adipocytes and chick embryo fibroblasts. Diabetes Care 1981 0.75
196 [Insulin-like growth factors (IGF I and IGF II) and diabetes]. Ther Umsch 1990 0.75
197 Effects of insulin-like growth factor (IGF) binding proteins (BPs) -3 and -6 on DNA synthesis of rat osteoblasts: further evidence for a role of auto-/paracrine IGF I but not IGF II in stimulating osteoblast growth. Biochem Biophys Res Commun 1995 0.75
198 Non-suppressible insulin-like activity in Laron's syndrome. Acta Endocrinol (Copenh) 1979 0.75
199 Recombinant human insulin-like growth factor binding proteins 4, 5, and 6: biological and physiochemical characterization. Growth Regul 1993 0.75
200 [Malignant hyperthermia: attempt at an early diagnosis by means of determination of creatine phosphokinase (CPK) and its isoenzymes]. Schweiz Med Wochenschr 1976 0.75
201 [IGFs/somatomedins: physiological and physiopathological significance]. Journ Annu Diabetol Hotel Dieu 1985 0.75
202 [The mode of action of insulin (author's transl)]. Ther Umsch 1976 0.75
203 Lipase activity in the fat cake and aqueous phase of adipose tissue homogenate of fed, fasted and fasted-refed rats. Eur J Clin Invest 1970 0.75
204 [Growth factors with identical insulino-situations : IGF I and II, NSILA and somatomedins (author's transl)]. Ann Endocrinol (Paris) 1981 0.75
205 Systemic and regional tumour metabolism in a patient with non-islet cell tumour hypoglycaemia: role of increased levels of free insulin-like growth factors. Diabetologia 1996 0.75
206 [Diagnosis in acromegaly. Insulin-like growth factor as a parameter of activity]. Dtsch Med Wochenschr 1983 0.75
207 Resistance to subcutaneous and intramuscular insulin associated with deficiency of insulin-like growth factor (IGF) 2. Metabolism 1983 0.75
208 Protein kinase and cyclic AMP-binding activities in liver and adipose tissue of normal, streptozotocin-diabetic and adrenalectomized rats. FEBS Lett 1973 0.75
209 Small stature and insulin-like growth factors: prolonged treatment of mini-poodles with recombinant human insulin-like growth factor I. Acta Endocrinol (Copenh) 1989 0.75